MUMBAI: Intas Pharmaceuticals, a vertically integrated pharma company, today said it expects to launch its first biosimilar in the US within 9-12 months. Intas is the only domestic firm with two ...

Intas has signed an exclusive agreement with SII-backed IntegriMedical to deploy needle-free injection systems across IVF ...

Melbourne drug delivery technology company Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) has signed a licensing agreement with Intas Pharmaceuticals Ltd, an India based pharmaceuticals company, for ...

Intas Pharmaceuticals has partnered with IntegriMedical to launch India's first needle-free injection system for IVF and gynecology treatments. This initiative aims to transform patient care by ...

HERCESSI(TM) becomes one of two trastuzumab biosimilars on preferred formulary placement, expanding patient access to more affordable HER2-targeted oncology therapies RALEIGH, N.C., Jan. 5, 2026 ...

Cisplatin is a type of chemotherapy drug used alone or in combination with other drugs to treat several advanced forms of cancer, including bladder, ovarian and testicular cancer. The FDA last week ...

Months after the FDA reported multiple violations at an Intas Pharmaceuticals plant in India and blocked imports, the agency shared more details Aug. 1, including a report of an analyst pouring acid ...

Intas collaborates with IntegriMedical to launch India’s first needle-free injection system for IVF and gynaecology: Our ...

Ahmedabad-based Intas Pharmaceuticals on Wednesday acquired Spanish drug maker Combino Pharm's hospital business in Spain and Portugal for an undisclosed amount. The acquisition will help Intas become ...

Mumbai: Intas Pharmaceuticals Ltd agreed to buy Actavis UK Ltd and Actavis Ireland Ltd from Israeli generic drug maker Teva Pharmaceutical Industries Ltd for an enterprise value of approximately £600 ...

The market for exits appears to be hotting up. ChrysCapital Investment Advisors, the fund which manages $2.5 billion, is understood to be scripting an exit from its portfolio company Intas Pharma ...

Intas Pharmaceuticals, which has been under scrutiny from the U.S. FDA lately, had its manufacturing site near Ahmedabad, India, slapped with an “import alert” by the agency. The admonishment comes ...